Pravata Kumar Pradhan
Research Subjects
Pravata Kumar Pradhan has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Thangaraj Raja Swaminathan
Peninsular and Marine Fish Genetic Resources Centre, ICAR-National Bureau of Fish Genetic Resources, CMFRI Campus, Kochi, India
9 shared publications - Neeraj Sood
ICAR-National Bureau of Fish Genetic Resources, Lucknow, India
8 shared publications Anutosh Paria
ICAR-National Bureau of Fish Genetic Resources, Canal Ring Road, P.O. Dilkusha, Lucknow, Uttar Pradesh 226002, India
4 shared publicationsDev K. Verma
ICAR-National Bureau of Fish Genetic Resources
4 shared publications- Manoj Kumar Yadav
National Bureau of Fish Genetic Resources, Canal Ring Road, P.O. Dilkusha, Lucknow 226 002, Uttar Pradesh, India
4 shared publications N. Sood
ICAR-National Bureau of Fish Genetic Resources, Canal Ring Road, P.O. Dilkusha, Lucknow 226002, Uttar Pradesh, India
4 shared publications
Latest Publications
- 9 March 2026
- Published by Springer Nature in Veterinary Research Communications
- Vol. 50 (3) , 189
Edwardsiella ictaluri infection in farmed striped catfish Pangasianodon hypophthalmus in India
- 9 March 2026
- Published by Springer Nature in Veterinary Research Communications
- Vol. 50 (3) , 189
Edwardsiella ictaluri infection in farmed striped catfish Pangasianodon hypophthalmus in India
- 1 September 2025
- Published by Springer Nature
- p. 849-865
Aquatic Animal Health Regulations and Policy in India
- 1 September 2025
- Published by Springer Nature
- p. 849-865
Aquatic Animal Health Regulations and Policy in India
- 1 September 2025
- Published by Springer Nature
- p. 109-138
Emerging Viral Diseases in Freshwater Fishes with Emphasis on Tilapia Lake Virus
- 1 September 2025
- Published by Springer Nature
- p. 109-138
Emerging Viral Diseases in Freshwater Fishes with Emphasis on Tilapia Lake Virus
- 1 September 2025
- Published by Springer Nature
- p. 867-880
National Surveillance Programme for Aquatic Animal Diseases (NSPAAD): Enhancing Aquatic Animal Health Preparedness in India
- 1 September 2025
- Published by Springer Nature
- p. 867-880
National Surveillance Programme for Aquatic Animal Diseases (NSPAAD): Enhancing Aquatic Animal Health Preparedness in India
- 13 October 2024
- Published by Springer Nature
- p. 199-221
Aquatic Animal Disease Surveillance and Important Disease Affecting Finfish and Shellfish in India
- 13 October 2024
- Published by Springer Nature
- p. 199-221
Aquatic Animal Disease Surveillance and Important Disease Affecting Finfish and Shellfish in India
- 1 January 2022
- Published by Elsevier in Virus Research
- Vol. 308, 198625
Reassortment and evolutionary dynamics of tilapia lake virus genomic segments
- 1 January 2022
- Published by Elsevier in Virus Research
- Vol. 308, 198625
Reassortment and evolutionary dynamics of tilapia lake virus genomic segments
- Open Access
Carps, Catla catla, Cirrhinus mrigala and Hypophthalmichthys molitrix Are Resistant to Experimental Infection with Tilapia Lake Virus (TiLV)
Tilapia tilapinevirus, also known as tilapia lake virus (TiLV), is an emerging fish virus that primarily affects tilapines. However, the virus has also been detected in a few non-tilapines. As tilapia is generally farmed in polyculture systems along with carps in South Asian countries, there is a likelihood that TiLV-infected tilapia can transmit the virus to the co-cultured species. In view of the above, the susceptibility of three carp species, namely catla (Catla catla), mrigal (Cirrhinus mrigala) and silver carp (Hypophthalmichthys molitrix) was evaluated vis-à-vis tilapia, following experimental infection with TiLV. No clinical signs and histopathological alterations could be observed in carps. RT-qPCR revealed that TiLV copy numbers in liver and brain of all the three carps were almost negligible and did not show any increase with time, suggesting that the virus did not replicate in liver and brain, the target organs of TiLV. Further, TiLV could not be isolated from pooled liver and brain tissues of carps using permissive CFF cell line. On the contrary, in tilapia, typical clinical signs and histopathological lesions were observed and there was significant increase in TiLV copy number up to 6 days post-injection. Furthermore, the virus was successfully isolated from pooled liver and brain tissue of infected tilapia. From the above findings, it could be concluded that C. catla, C. mrigala and H. molitrix are resistant to TiLV infection and unlikely to be carriers for this virus.
Open AccessCarps, Catla catla, Cirrhinus mrigala and Hypophthalmichthys molitrix Are Resistant to Experimental Infection with Tilapia Lake Virus (TiLV)
Tilapia tilapinevirus, also known as tilapia lake virus (TiLV), is an emerging fish virus that primarily affects tilapines. However, the virus has also been detected in a few non-tilapines. As tilapia is generally farmed in polyculture systems along with carps in South Asian countries, there is a likelihood that TiLV-infected tilapia can transmit the virus to the co-cultured species. In view of the above, the susceptibility of three carp species, namely catla (Catla catla), mrigal (Cirrhinus mrigala) and silver carp (Hypophthalmichthys molitrix) was evaluated vis-à-vis tilapia, following experimental infection with TiLV. No clinical signs and histopathological alterations could be observed in carps. RT-qPCR revealed that TiLV copy numbers in liver and brain of all the three carps were almost negligible and did not show any increase with time, suggesting that the virus did not replicate in liver and brain, the target organs of TiLV. Further, TiLV could not be isolated from pooled liver and brain tissues of carps using permissive CFF cell line. On the contrary, in tilapia, typical clinical signs and histopathological lesions were observed and there was significant increase in TiLV copy number up to 6 days post-injection. Furthermore, the virus was successfully isolated from pooled liver and brain tissue of infected tilapia. From the above findings, it could be concluded that C. catla, C. mrigala and H. molitrix are resistant to TiLV infection and unlikely to be carriers for this virus.
- 1 April 2021
- Published by Elsevier in Fish & Shellfish Immunology
- Vol. 111, 208-219
Transcriptome analysis of liver elucidates key immune-related pathways in Nile tilapia Oreochromis niloticus following infection with tilapia lake virus
- 1 April 2021
- Published by Elsevier in Fish & Shellfish Immunology
- Vol. 111, 208-219
Transcriptome analysis of liver elucidates key immune-related pathways in Nile tilapia Oreochromis niloticus following infection with tilapia lake virus
- 10 February 2020
- Published by Wiley in Journal of the World Aquaculture Society
- Vol. 51 (2) , 563-570
Large‐scale mortality in cultured tilapia Oreochromis niloticus due to infection with Shewanella putrefaciens in India
In recent years, infection with Shewanella putrefaciens has emerged as a serious problem in freshwater aquaculture. In the present study, we report large‐scale mortality in farmed tilapia Oreochromis niloticus from Hisar, North India. The diseased tilapia exhibited lethargy, swimming near the water surface, fin rot, hemorrhages on the operculum, and approximately 40% mortality. Gram‐negative, motile, catalase, and oxidase‐positive bacilli were isolated from the kidney of affected tilapia and confirmed as S. putrefaciens on the basis of biochemical tests and 16S rRNA gene sequencing. The antimicrobial sensitivity test revealed that S. putrefaciens strains were sensitive to quinolone, nitrofuran, tetracycline, aminoglycoside, cephalosporin, aminocyclitol, sulphonamide, and macrolide antibiotics, but resistant to beta‐lactam and glycopeptide antibiotics. The histopathological examination revealed degenerative changes in the kidney, liver, spleen, and intestine suggesting systemic infection. In experimental infection studies, the disease was reproduced in naive tilapia, and the clinical signs resembled those observed in natural cases. Further more, S. putrefaciens was re‐isolated from the kidney of challenged tilapia, fulfilling Koch's postulates. Therefore, the mortality in tilapia was attributed to S. putrefaciens infection.
- 10 February 2020
- Published by Wiley in Journal of the World Aquaculture Society
- Vol. 51 (2) , 563-570
Large‐scale mortality in cultured tilapia Oreochromis niloticus due to infection with Shewanella putrefaciens in India
In recent years, infection with Shewanella putrefaciens has emerged as a serious problem in freshwater aquaculture. In the present study, we report large‐scale mortality in farmed tilapia Oreochromis niloticus from Hisar, North India. The diseased tilapia exhibited lethargy, swimming near the water surface, fin rot, hemorrhages on the operculum, and approximately 40% mortality. Gram‐negative, motile, catalase, and oxidase‐positive bacilli were isolated from the kidney of affected tilapia and confirmed as S. putrefaciens on the basis of biochemical tests and 16S rRNA gene sequencing. The antimicrobial sensitivity test revealed that S. putrefaciens strains were sensitive to quinolone, nitrofuran, tetracycline, aminoglycoside, cephalosporin, aminocyclitol, sulphonamide, and macrolide antibiotics, but resistant to beta‐lactam and glycopeptide antibiotics. The histopathological examination revealed degenerative changes in the kidney, liver, spleen, and intestine suggesting systemic infection. In experimental infection studies, the disease was reproduced in naive tilapia, and the clinical signs resembled those observed in natural cases. Further more, S. putrefaciens was re‐isolated from the kidney of challenged tilapia, fulfilling Koch's postulates. Therefore, the mortality in tilapia was attributed to S. putrefaciens infection.
- 1 December 2019
- Published by Elsevier in Gene Expression Patterns
- Vol. 34, 119071
Ontogeny and tissue-specific expression of immune-relevant genes in Catla catla (Hamilton)
- 1 December 2019
- Published by Elsevier in Gene Expression Patterns
- Vol. 34, 119071
Ontogeny and tissue-specific expression of immune-relevant genes in Catla catla (Hamilton)